ToI podcast

Daily Briefing Sept. 1: NY law addresses Holocaust education; an opioid antidote?

US reporter Luke Tress looks at Holocaust art education in NY and opioid crisis; Jessica Steinberg discusses Aviv Geffen’s abrupt political shift and rebates for film/TV producers

Welcome to The Times of Israel’s Daily Briefing, your 15-minute audio update on what’s happening in Israel, the Middle East and the Jewish world, from Sunday through Thursday.

US reporter Luke Tress joins host Jessica Steinberg for today’s podcast.

Tress discusses recent New York State legislation regarding Nazi-looted art, with a new education law that requires museums to label artwork plundered by the Nazis.

Steinberg talks about rocker Aviv Geffen and his abrupt political transformation from ardent leftist to performing in Israeli West Bank settlements.

Tress looks at the opioid epidemic in the Jewish community in the US and the efforts of a Jewish UK doctor who is developing a drug antidote to combat fentanyl overdoses.

Finally, Steinberg mentions a long-awaited government decision to offer 30% rebates for foreign TV and film productions in Israel.

Discussed articles include:

Narcan inventor developing new overdose treatment to combat fentanyl scourge

Rocker Aviv Geffen changes his tune with West Bank concerts for ‘brother’ settlers

Seeking to woo TV and filmmakers, Israel offers 30% rebate to sweeten the deal

Subscribe to The Times of Israel Daily Briefing on iTunes, Spotify, PlayerFM, Google Play, or wherever you get your podcasts.

Check out yesterday’s Daily Briefing episode:

 

Most Popular
read more:
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.